• 15 June 2010
  • News
  • By

45-47-Clinigene-Hester Biosciences-Max Neeman International

45
Clinigene

CMD Dr Kiran Mazumdar Shaw
Business Clinical research
Start-up Year 2000
Biotech Revenue Rs 39 crore
Address Clinigene House, Tower 1, Semicon Park, Electronic City, Phase II, Bangalore-560100
Tel +91-80-28082728
Fax +91-80-28522989
Website www.clinigeneintl.com

Clinigene International, the clinical research arm of biotech major Biocon, has grossed Rs 39 crore as revenue for the fiscal year ended March 31, 2010. Clinigene  is a full-service CRO that partners global pharma and biotech companies in their clinical development programs. Established in 2000, Clinigene became India’s first CAP accredited Central Laboratory followed by NABL accreditation in 2003. Clinigene’s services now span a broad spectrum of activities—human pharmacology, clinical operations, clinical development, clinical data management and  biostatistics, regulatory, bioanalytical research and central laboratory services supporting early phase through late-phase clinical development programs. All activities are carried out in strict compliance with regulatory and ICH GCP requirements. Its comprehensive investigator database and expertise in many therapeutic areas helps in providing faster patient recruitment, cost competitive trials, yet world-class clinical support.

46
Hester Biosciences

CEO & MD Rajiv Gandhi
Business Manufacturing of Poultry Vaccines
Start-up Year 1997
Biotech Revenue Rs 37.53 crore
Address 16/10 Devendra Society, Naranpura, Ahmedabad-380013
Tel +91-79-27680476
Fax +91-79-27682250
Website www.hesterbiosciences.co.in

Veterinary vaccines manufacturer, Hester Biosciences has registered an annual turnover of Rs 37.53 crore in fiscal 2009-2010. Located near Ahmedabad, Hester is ISO 9001-2000 and GMP certified. The product range includes 39 types of poultry vaccines, 28 types of live and 11 types of inactivated poultry vaccines. Hester has a state-of-the-art facility to produce live and inactivated veterinary vaccines.  It has a capacity to manufacture over five billion doses of animal vaccines, with the current capacity utilization at 35 percent.
Apart from export of vaccines, Hester  imports one vaccine from the US.  Exports are currently done to three countries and registration is pending in over 10 countries.  Besides marketing its own vaccines, Hester represent companies like Merial, US and Biopharm, Czech Republic for poultry vaccines; and Synbiotics, US for animal diagnostic kits for the Indian market.  Hester currently is also looking at establishing a base either in the US or Europe as a means to achieve its global ambitions.

47
Max Neeman International
MD Deepak Kapoor
Business Production and marketing of poultry biologicals
Start-up Year 1991
Biotech Revenue Rs 36.94 crore
Address Corporate Heights, SCO-24, Sector-14, Gurgaon-122 001
Tel +91-124-22315045
Fax -
Website  www.indovax.com

The accumulated revenue for Indovax for the fiscal 2009-2010 is Rs 36.94. Indovax has been engaged in the production of poultry biologicals since 1991. Its product portfolio consists of viral and inactivated vaccines. Some of them are Newcastle vaccine (Ranikhet vaccine), Gumboro vaccine (IBD), Marek’s vccine, infectious bronchitis vaccine, fowl pox vaccine, fowl cholera vaccine and infectious coryza vaccine. It has a modern state-of-the-art facility spread over 14 acres in a
completely poultry-free zone. The company has been focusing on  introducing  a new product every six months.

Indovax in joint venture with Gezondheidsdienst voor Dieren BV, a Dutch entity and one of the world’s largest veterinary diagnostic laboratories are executing a collaborative biotechnology project to produce SPF Embryonated eggs and Diagnostic reagents. The Project under execution in Himachal Pradesh is supported by the Dutch Government.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X